Alphatec ( (ATEC) ) has released its Q2 earnings. Here is a breakdown of the information Alphatec presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Alphatec Holdings, Inc. is a medical device company focused on revolutionizing spine surgery through innovative solutions, operating primarily in the spine sector. In its latest earnings report, Alphatec announced a significant increase in both surgical and total revenue for the second quarter of 2025, with surgical revenue growing by 29% to $168 million and total revenue increasing by 27.5% to $186 million. The company also raised its full-year guidance for revenue and profitability. Key financial metrics reveal a GAAP gross margin of 70% and a non-GAAP net income of $3 million, marking a shift to profitability. The company achieved an adjusted EBITDA of $23 million with a margin of 13%, reflecting disciplined execution and strategic growth. Looking ahead, Alphatec expects a 21% growth in total revenue for the full year 2025, with a revised expectation of $742 million, indicating continued confidence in its strategic direction and market position.